Eleven sell-side analysts currently cover NIO Inc., collectively assigning an average rating of Hold. Within this cohort, two analysts recommend Sell, six Rate Hold, and three Rate Buy. The mean 12-month price target stands at $6.73, reflecting a modest upside potential from current levels. Notable revisions include Mizuho’s upgrade of its target from $6.00 to $7.00 with a Neutral stance and Macquarie’s assignment of a $5.30 objective. UBS Group and Goldman Sachs both maintain Neutral ratings, underscoring a broad expectation of sideways share movement in the near term.

Institutional investors hold 48.6% of NIO’s outstanding shares. During the second quarter, Kingstone Capital Partners Texas added a new $12.3 million position, while American Century Companies increased its stake by 37.4% to 965,409 shares. Vontobel Holding more than doubled its position, acquiring 608,377 additional shares to total 1,094,398. WMG Financial Advisors boosted its holding by 17.9% to 474,966 shares, and Marex Group initiated a $0.9 million position. These moves suggest renewed confidence among larger allocators ahead of potential catalyst events.

NIO reports a market capitalization near $9.7 billion and carries a debt-to-equity ratio of 2.36. Liquidity measures include a current ratio of 0.94 and a quick ratio of 0.83, indicating tight short-term coverage of liabilities. The trailing P/E ratio stands at negative 3.20 as the company continues to invest heavily in R&D and manufacturing capacity. NIO’s beta of 1.05 highlights a share price trajectory closely aligned with broader equity markets, while its 50-day and 200-day moving averages of $5.49 and $5.63, respectively, offer technical reference points for traders monitoring momentum.